Cadrenal Therapeutics Highlights Recent 12-LOX Inhibitor Platform Expansion
Go back to Cadrenal Therapeutics Highlights Recent 12-LOX Inhibitor Platform Expansion| (NASDAQ: CVKD) | Delayed: 2.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.01 | 52 Week High | $ | |||
| Open | $2.01 | 52 Week Low | $ | |||
| Day High | $2.01 | P/E | N/A | |||
| Day Low | $2.01 | EPS | $ | |||
| Volume | 165 | |||||
